Cercle

Cercle is an AI technology company focused on advancing women's healthcare through data-driven insights. Founded in 2023, the company's primary offering is the Cercle Biomedical Graph, an AI-powered platform that ingests and transforms unstructured healthcare data into actionable insights for women's healthcare providers. The platform collects billions of de-identified biomedical and genomics data points from healthcare clinics and research labs worldwide, converting them into a standardized format for use by clinicians, researchers, and other stakeholders in the healthcare ecosystem.

Initially focusing on fertility care, Cercle's technology aims to enable more personalized and precise treatment plans based on anonymized medical histories from a diverse patient base. The platform is designed to help clinics improve efficiency, accelerate medical discoveries, and ultimately drive better health outcomes for women. As of September 2024, Cercle's technology was being used by notable fertility providers such as US Fertility, Boston IVF, and Eurofins Genoma to inform personalized treatments and optimize clinical workflows.

Cercle's mission is to address the data gap in women's healthcare, an area that has historically been under-researched and underfunded. The company's AI technology harmonizes and transforms raw, fragmented medical data, which comprises up to 80% of all medical data, into accurate insights to improve patient outcomes. The platform is HIPAA and GDPR compliant, ensuring high standards of data privacy and security.

Key customers and partnerships

Cercle has established partnerships with several prominent healthcare institutions. US Fertility, the largest fertility network in the US supporting over 100 clinics, uses Cercle's platform to organize unstructured, de-identified clinical data for analysis, optimizing research and internal quality assurance capabilities. Eurofins Genoma, a global provider of DNA sequencing services, has partnered with Cercle to bring the Cercle Biomedical Graph to hundreds of fertility and genetics clinics across Europe. Boston IVF, another major fertility provider, also utilizes Cercle's technology to drive efficiency and inform personalized treatments for patients.